Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioCryst Pharmaceuticals, Inc. - Common Stock
(NQ:
BCRX
)
9.265
+0.195 (+2.15%)
Streaming Delayed Price
Updated: 11:06 AM EDT, Aug 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioCryst Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
BCRX Stock Earnings: BioCryst Pharma Beats EPS, Beats Revenue for Q1 2024
↗
May 06, 2024
BCRX stock results show that BioCryst Pharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Hidden Penny Gems: 7 Stocks With Triple-Digit Growth Prospects
↗
March 01, 2024
These penny stocks offer triple digit returns to investors right now but not many investors are aware of them.
Via
InvestorPlace
BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript
↗
February 26, 2024
BCRX earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
What's Going On With BioCryst Stock After Earnings?
↗
February 26, 2024
BioCryst reported quarterly losses of 28 cents per share, missing the analyst consensus estimate of losses of 24 cents by 16.67% and representing a 26.32% increase over losses of 38 cents per share...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
February 26, 2024
Via
Benzinga
A Preview Of BioCryst Pharma's Earnings
↗
February 23, 2024
Via
Benzinga
What's Going On With BioCryst Pharmaceuticals Stock?
↗
January 08, 2024
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) shares are trading higher Monday.
Via
Benzinga
Where BioCryst Pharma Stands With Analysts
↗
November 20, 2023
Via
Benzinga
Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session
↗
February 26, 2024
U.S. stock futures were lower this morning, with the Dow futures trading lower by over 50 points on Monday.
Via
Benzinga
Topics
Stocks
Earnings Scheduled For February 26, 2024
↗
February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million.
Via
Benzinga
What 7 Analyst Ratings Have To Say About BioCryst Pharma
↗
September 25, 2023
Via
Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
January 08, 2024
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...
Via
Benzinga
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
December 06, 2023
Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.
Via
Benzinga
Analyst Expectations for BioCryst Pharma's Future
↗
May 04, 2023
Via
Benzinga
BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript
↗
November 03, 2023
BCRX earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
↗
September 18, 2023
Via
Benzinga
3 Magnificent Growth Stocks to Buy on the Dip
↗
August 28, 2023
These three biotech stocks are attractive buys right now.
Via
The Motley Fool
Why BioCryst Pharmaceuticals Stock Is Soaring Today
↗
May 03, 2023
The biotech's Q1 earnings report contained a number of positives.
Via
The Motley Fool
BioCryst Clocks 37.8% Revenue Growth In Q1 On Solid New Patient Growth
↗
May 03, 2023
Via
Benzinga
Recap: BioCryst Pharma Q1 Earnings
↗
May 03, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
↗
August 04, 2023
Via
Benzinga
BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript
↗
August 03, 2023
BCRX earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023
↗
July 13, 2023
Via
Benzinga
Why Shares of BioCryst Pharmaceuticals Jumped Today
↗
February 22, 2023
A day after the stock plummeted, it bounced back.
Via
The Motley Fool
BioCryst Pharmaceuticals (BCRX) Q1 2023 Earnings Call Transcript
↗
May 03, 2023
BCRX earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Why Is BioCryst Pharmaceuticals (BCRX) Stock Down 8% Today?
↗
April 18, 2023
BioCryst Pharmaceuticals (BCRX) stock is slipping on Tuesday after the biotech company announced new funding to pay down debts.
Via
InvestorPlace
Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday
↗
April 18, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Analyst Sees Attractive Entry Opportunity After BioCryst's Pipeline Setback
↗
February 22, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
↗
February 22, 2023
Via
Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
February 21, 2023
Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
